ReviewIJID regions2025
Perspectives on tuberculosis in migrants, refugees, and displaced populations in Europe.
Review in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07609264 (Making Sense of Tuberculosis), which is not on this map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Making Sense of Tuberculosis (TB) Related Stigma in a Low-incidence Area of the UK: Patients Experiences and Everyday Responses
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence of latent tuberculosis infection in Malaysia: the first systematic review and meta-analysis.BMC infectious diseases · 2026Pooled it
- Tuberculosis in transit: risk factors in Tanzania's high-mobility border regions.The Pan African medical journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Finding and treating all forms of tuberculosis (TB) (latent, drug-susceptible, drug-resistant, multidrug-resistant, and extensively drug-resistant tuberculosis) among migrants, displaced populations, and refugees are important challenges facing TB control programs in Europe. Many of these populations live in poor conditions, with limited access to healthcare and TB services. Ever-increasing armed conflicts in Europe and other parts of the world continue to exacerbate rates of migration to and within Europe, with considerable implications for health services. TB in Europe is more prevalent in migrants from high TB-endemic areas, as well as those with social risk factors, including poverty and poor housing or homelessness. We provide our perspectives on recent data on TB in Europe from the World Health Organization, the European Centre for Disease Prevention and Control, the United Kingdom Health Security Agency, and other 2023-2024 reports. Despite advancements in TB screening and prevention strategies, and treatment regimens including community-based and integrated multi-disease approaches, significant challenges remain. These include variations in national policies, resource limitations, and barriers to accessing healthcare. To help address these challenges, there is a need for clearer guidance through national policies, enhanced surveillance, and proactive community engagement There is also an urgent need for more investment into TB health services in Europe for refugees, migrants, and other displaced populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.